|
22 Sep 2025 |
UltraTech Cement
|
Consensus Share Price Target
|
12508.00 |
13764.17 |
- |
10.04 |
buy
|
|
|
|
|
20 Oct 2023
|
UltraTech Cement
|
Axis Direct
|
12508.00
|
9680.00
|
8461.05
(47.83%)
|
Target met |
Buy
|
|
|
The stock is currently trading at 17x and 14x FY24E/FY25E EV/EBITDA. We maintain our BUY rating on the stock with a TP of Rs 9,680/share, implying an upside potential of 14% from the CMP.
|
|
20 Oct 2023
|
UltraTech Cement
|
SMC online
|
12508.00
|
|
8461.05
(47.83%)
|
|
Results Update
|
|
|
|
|
20 Oct 2023
|
UltraTech Cement
|
ICICI Securities Limited
|
12508.00
|
8742.00
|
8518.55
(46.83%)
|
Target met |
Hold
|
|
|
UltraTech Cement (UTCEM)’s Q2FY24 performance was largely in line with our estimate. Yet, management’s commentary on pricing (which corroborates with our channel checks) is propelling an EBITDA upgrade of 7% for FY24E and 13% for FY25E.
|
|
19 Oct 2023
|
UltraTech Cement
|
Sharekhan
|
12508.00
|
9500.00
|
8518.55
(46.83%)
|
Target met |
Buy
|
|
|
|
|
30 Aug 2023
|
UltraTech Cement
|
Sharekhan
|
12508.00
|
9500.00
|
8265.95
(51.32%)
|
Target met |
Buy
|
|
|
|
|
27 Jul 2023
|
UltraTech Cement
|
BOB Capital Markets Ltd.
|
12508.00
|
9396.00
|
8288.25
(50.91%)
|
Target met |
Hold
|
|
|
Grey cement volumes grew 20% YoY to 28.6mt in Q1; utilisation healthy at ~86%
|
|
24 Jul 2023
|
UltraTech Cement
|
SMC online
|
12508.00
|
|
8219.85
(52.17%)
|
|
Results Update
|
|
|
|
|
24 Jul 2023
|
UltraTech Cement
|
IDBI Capital
|
12508.00
|
8837.00
|
8219.85
(52.17%)
|
Target met |
Hold
|
|
|
|
|
24 Jul 2023
|
UltraTech Cement
|
ICICI Securities Limited
|
12508.00
|
7311.00
|
8119.20
(54.05%)
|
|
Sell
|
|
|
The 20% volume surge reported by UltraTech Cement in Q1FY24 failed to drive EBITDA growth (down 1.5% YoY). EBITDA/te dipped 3% QoQ (~7% below consensus and in line with our estimate) due to: a) realisation decline of 0.4% QoQ, b) variable cost/te being flat QoQ despite low fuel prices, and c) fixed cost/te rising 10% QoQ.
|
|
24 Jul 2023
|
UltraTech Cement
|
Axis Direct
|
12508.00
|
9520.00
|
8219.85
(52.17%)
|
Target met |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|